Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · International Stock · Columbia Threadneedle

Columbia Overseas Core Fund Columbia Overseas Core Fund Institutional 3 Class (COSOX)

Ticker COSOX · Since 2018-03-05 · · Holdings as of May 31, 2026

Expense ratio
0.79%$79/yr per $10k
5-yr return
+9.2%annualized
1-yr return
+38.4%as of Dec 2025
Net assets
$997.5Mall share classes
Holdings
129

Bottom line

Is COSOX a good fund? The bottom line

COSOX is a share class of Columbia Overseas Core Fund, an actively managed international stock mutual fund from Columbia Threadneedle.

Annual fees run 0.79% — about $79 a year on every $10,000 invested, cheaper than 64% of international stock funds we track.

It returned +38.4% over one year, +9.2% a year over five years (as of Dec 31, 2025, per its prospectus).

With $998 million in net assets and 129 holdings, its largest position is ING Groep NV (2.4%) and the top 10 make up 20.7% of the portfolio.

What stands out

  • 5-year return beat 77% of category peers
  • No front-end sales load

Updated Nov 19, 2026

What COSOX invests in

Columbia Overseas Core Fund (the Fund) seeks to provide shareholders with long-term capital appreciation.

Under normal circumstances, the Fund invests at least 80% of its net assets ( plus the amount of any borrowings for investment purposes) in equity securities of foreign companies. The Fund may invest up to 20% of its net assets in emerging market countries. The Fund may invest directly in foreign equity securities, such as common and preferred stock, or indirectly through mutual funds and closed-end funds, as well as depositary receipts. The Fund may invest in securities of or relating to issuers believed to be undervalued (i.e., value stocks), represent growth opportunities (i.e., growth stocks), or both. The Fund may invest in the securities of issuers of any size, including small-, mid- and large-capitalization companies. The Fund may invest in companies involved in initial public offerings, tender offers, mergers, other corporate restructurings and other special situations. The…

From the fund's prospectus (filed Jun 25, 2026).

COSOX performance

Average annual total returns
1 yr5 yr10 yr
COSOX+38.4%+9.2%—
International Stock median+25.5%+6.4%+7.6%

Source: Fund prospectus, as of Dec 31, 2025

Full COSOX performance history →

What COSOX costs

On a $10,000 investment, COSOX's 0.79% expense ratio costs about $79 a year. The prospectus estimates $1,098 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.

See the full COSOX fee table →

COSOX top 10 holdings

#Holding% of fund
1ING Groep NV2.43%
2Shell PLC2.27%
3AstraZeneca PLC2.25%
4Primo Brands Corp2.17%
5ASM International NV2.16%
6Powszechna Kasa Oszczednosci Bank Polski SA2.02%
7Columbia Short Term Cash Fund1.89%
8National Bank of Greece SA1.87%
9Mitsubishi UFJ Financial Group Inc1.82%
10Axa Sa1.79%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 20.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to COSOX

More funds like COSOX →

COSOX FAQ

What is the expense ratio of COSOX?
COSOX's expense ratio is 0.79%, which works out to about $79 a year for every $10,000 invested. The prospectus estimates total costs of $1,098 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is COSOX a good investment?
It depends on your goals, but the data points to: 5-year return beat 77% of category peers; no front-end sales load. This is general information, not personalized advice.
What does COSOX hold?
COSOX's largest holdings are ING Groep NV (2.4%), Shell PLC (2.3%), AstraZeneca PLC (2.3%), Primo Brands Corp (2.2%), ASM International NV (2.2%). It holds 129 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is COSOX's 5-year return?
COSOX returned +9.2% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Does COSOX have a sales load?
No. COSOX has no front-end sales charge.
Who manages COSOX?
COSOX is offered by Columbia Threadneedle through Columbia Funds Series Trust II.